754230-78-9

Basic information

• Product Name: 2-Amino-5-bromo-3-benzloxypyridine
• Synonyms: 2-Amino-5-bromo-3-benzloxypyridine;2-Amino-5-bromo-3-benzyloxypyridine;3-Benzyloxy-5-bromo-2-pyridinamine;5-bromo-3-(phenylmethoxy)- 2-Pyridinamine;3-(benzyloxy)-5-bromopyridin-2-amine;2-PyridinaMine, 5-broMo-3-(phenylMethoxy)-;2-AMino-3-benzyloxy-5-broMopyridine, 96%;3-(benzyloxy)-5-bromopyridine-2-amine
• CAS NO: 754230-78-9
• Molecular Formula: C₁₂H₁₁BrN₂O
• Molecular Weight: 279.13
• Mol File: 754230-78-9.mol
• Article Data: 27

Chemical Properties

• Melting Point: 99 ºC
• Boiling Point: 376.7 °C at 760 mmHg
• Flash Point: 181.6 °C
• Appearance: /
• Density: 1.502
• Vapor Pressure: 7.11E-06mmHg at 25°C
• Refractive Index: 1.645
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 2-Amino-5-bromo-3-benzloxypyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Amino-5-bromo-3-benzloxypyridine(754230-78-9)
• EPA Substance Registry System: 2-Amino-5-bromo-3-benzloxypyridine(754230-78-9)

Safety Data

• Hazardous Substances Data: 754230-78-9(Hazardous Substances Data)

Usage

General Description

2-Amino-5-bromo-3-benzyloxypridine, also known as Aminophenazone, is a chemical compound with the formula C11H10BrN3O. It is a heterocyclic aromatic compound containing a pyridine ring. This chemical is most commonly used as a pharmaceutical intermediate, and is also known for its potential to act as an antipyretic, analgesic, and anti-inflammatory agent. Additionally, it has been found to have potential application as a corrosion inhibitor and as a building block in the synthesis of various biologically active compounds. This chemical has the potential for various research and industrial applications due to its diverse properties and potential uses.

InChI:InChI=1/C12H11BrN2O/c13-10-6-11(12(14)15-7-10)16-8-9-4-2-1-3-5-9/h1-7H,8H2,(H2,14,15)

Upstream product

• 24016-03-3 2-amino-3-benzyloxypyridine 
• 100-39-0 benzyl bromide 
• 16867-03-1 2-amino-3-hydroxypyridine 
• 144-55-8 sodium hydrogencarbonate 
• 39903-01-0 2-amino-3-hydroxy-5-bromopyridine 
• 100-44-7 benzyl chloride 

Downstream Products

• 362525-67-5 8-benzyloxy-6-bromo-2,3-dimethylimidazo[1,2-a]pyridine 
• 877619-67-5 4-(6-amino-5-benzyloxy-pyridin-3-yl)-benzoic acid 
• 1286716-32-2 ethyl 6-bromo-2-(chloromethyl)-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-33-3 ethyl 6-bromo-8-hydroxy-2-((phenylthio)methyl)imidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-36-6 ethyl 6-bromo-2-((4-fluorophenylthio)methyl)-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-34-4 ethyl 6-bromo-2-((4-chlorophenylthio)methyl)-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-37-7 ethyl 6-bromo-2-((4-bromophenylthio)methyl)-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-35-5 ethyl 6-bromo-8-hydroxy-2-((p-tolylthio)methyl)imidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-38-8 ethyl 6-bromo-8-hydroxy-2-((3-methoxyphenylthio)methyl)imidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-10-6 ethyl 6-bromo-8-hydroxy-2-((phenylthio)methyl)-7-(pyrrolidin-1-ylmethyl)imidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-12-8 ethyl 6-bromo-8-hydroxy-2-((phenylthio)methyl)-7-(piperidin-1-ylmethyl)imidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-13-9 ethyl 6-bromo-8-hydroxy-7-((4-methylpiperazin-1-yl)methyl)-2-((phenylthio)methyl)imidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-15-1 ethyl 6-bromo-7-((dimethylamino)methyl)-2-((4-fluorophenylthio)methyl)-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylate 
• 1286716-17-3 ethyl 6-bromo-2-((4-fluorophenylthio)methyl)-8-hydroxy-7-(pyrrolidin-1-ylmethyl)imidazo[1,2-a]pyridine-3-carboxylate 

Relevant articles and documents

Discovery of a novel series of guanidinebenzoates as gut-restricted enteropeptidase and trypsin dual inhibitors for the treatment of metabolic syndrome

A novel series of guanidinebenzoate enteropeptidase and trypsin dual inhibitors has been discovered and SAR studies were conducted. Optimization was focused on improving properties for gut restriction, including increased aqueous solubility, lower cellular permeability, and reduced oral bioavailability. Lead compounds were identified with efficacy in a mouse fecal protein excretion study.

CYANO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE

The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for preparation thereof, to the use thereof, alone or in combinations, for the treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular disorders.

SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE

The present application relates to novel substituted imidazo[1,2-a]pyridine-3-carboxamides, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of cardiovascular disorders.